Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

iChip01:24

iChip

The cultivation of environmental microorganisms has long been hindered by the inability to replicate complex native conditions in vitro. The isolation chip (iChip) addresses this limitation by facilitating the growth of previously uncultivable microorganisms through in situ incubation. Designed for high-throughput microbial cultivation, the iChip comprises hundreds of microchambers, each capable of housing a single microbial cell. These microchambers are loaded with a mixture of molten agar and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the Two-Step TSH Screening Protocol for Congenital Hypothyroidism: Prevalence and Diagnostic Accuracy in Ninh Binh, Vietnam.

Journal of the ASEAN Federation of Endocrine Societies·2026
Same author

Chemoport-related right innominate vein stenosis in patients with colorectal cancer: A retrospective risk factor analysis.

PloS one·2026
Same author

Spinal cord extracellular matrix hydrogel enhances organoid maturation and functional regeneration after spinal cord injury.

Materials today. Bio·2026
Same author

Benzyl-Spacer-Engineered Prodrug: Enabling NIR Fluorescent Activation for Cancer Therapy in a Zebrafish Gallbladder Model.

Journal of medicinal chemistry·2026
Same author

A new insight of a pH-dependent fluorescence switching mechanism and the novel radical scavenging ability of nitrogen-doped citric acid-based carbon dots.

RSC advances·2026
Same author

Reply Re: "A Safer and Easier Method to Open the Orbital Septum: Septal Ballooning".

Ophthalmic plastic and reconstructive surgery·2026

Related Experiment Video

Updated: May 22, 2026

Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR
09:16

Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR

Published on: February 5, 2018

HPV 9G DNAChip: Based on the 9G DNAChip technology.

Keum-Soo Song1, Satish Balasaheb Nimse, Heejung An

  • 1Biometrix Technology, Inc. 202 BioVenture Plaza, Chuncheon 200-161, Republic of Korea.

Journal of Virological Methods
|May 8, 2012
PubMed
Summary

The novel HPV 9G DNAChip accurately detects and differentiates HPV genotypes in clinical samples. This diagnostic tool shows 100% agreement with sequencing, offering precise human papillomavirus genotyping.

More Related Videos

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens
13:45

Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens

Published on: April 27, 2011

Related Experiment Videos

Last Updated: May 22, 2026

Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR
09:16

Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR

Published on: February 5, 2018

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens
13:45

Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens

Published on: April 27, 2011

Area of Science:

  • Molecular Diagnostics
  • Virology
  • Genomics

Background:

  • Human Papillomavirus (HPV) infection is a major cause of cervical cancer.
  • Accurate HPV genotyping is crucial for effective patient management and prevention strategies.
  • Existing diagnostic methods can be time-consuming or lack comprehensive genotype coverage.

Purpose of the Study:

  • To develop and evaluate the HPV 9G DNAChip for sensitive and specific detection of HPV genotypes.
  • To assess the performance of the HPV 9G DNAChip against established sequencing methods.
  • To determine the diagnostic accuracy of the HPV 9G DNAChip for clinical samples.

Main Methods:

  • Development of the HPV 9G DNAChip assay for HPV detection.
  • Optimization of hybridization and washing conditions (30 min hybridization, 2x2 min washing at 25°C).
  • Comparative analysis of HPV 9G DNAChip results with sequencing for 959 HPV-positive and 82 HPV-negative clinical samples.

Main Results:

  • The HPV 9G DNAChip demonstrated a high signal-to-background ratio (SBR) of 50-70.
  • Achieved 100% target-specific hybridization under optimized conditions.
  • Showed 100% agreement with sequencing for both HPV-positive and HPV-negative samples.
  • Successfully discriminated 19 different HPV genotypes in positive samples.

Conclusions:

  • The HPV 9G DNAChip is a highly accurate tool for HPV genotyping.
  • Its performance characteristics, including high SBR and specificity, make it suitable for clinical diagnostics.
  • The assay's efficiency and accuracy at low temperatures offer a promising advancement in HPV detection.